REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ongeno Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Ambulatory Health Care Services | Offices of Physicians | Outpatient Care Centers | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals
Full name: Ongeno Sp. z o.o. Profile Updated: July 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Ongeno Sp. z o.o. is an enterprise based in Poland. Its main office is in Krakow. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The enterprise was incorporated on April 27, 2017. Its’ total assets recorded a negative growth of 49.34%.

Headquarters
Ul. Grzegorzecka 67D/26
Krakow; Malopolskie; Postal Code: 31-559

Contact Details: Purchase the Ongeno Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ongeno Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Ongeno Sp. z o.o. report to view the information.
Incorporation Date:
April 27, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
35%
Purchase this report to view the information.
15%
Purchase this report to view the information.
15%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Ongeno Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-99.96%▼
Operating profit (EBIT)
-93.64%▼
Net Profit (Loss) for the Period
-93.22%▼
Total assets
-49.34%▼
Total equity
-48.66%▼
Return on Equity (ROE)
-69.6%▼
Quick Ratio
-5.02%▼
Cash Ratio
-5.6%▼

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Sartorius Stedim Poland Sp. z o.o.
 
Polpharma Biologics S.A.
Heart Sense Sp. z o.o.
 
Centrum Transferu Technologii Meditransfer Iitd Sp. z o.o.
Bio Omega Sp. z o.o.
 
Ticusia Sp. z o.o.
Forpi Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo